819 related articles for article (PubMed ID: 14578966)
41. Molecular analysis of SMN1, SMN2, NAIP, GTF2H2, and H4F5 genes in 157 Chinese patients with spinal muscular atrophy.
He J; Zhang QJ; Lin QF; Chen YF; Lin XZ; Lin MT; Murong SX; Wang N; Chen WJ
Gene; 2013 Apr; 518(2):325-9. PubMed ID: 23352792
[TBL] [Abstract][Full Text] [Related]
42. [Quantitative analysis of the genes determining spinal muscular atrophy].
Nagymihály M; Herczegfalvi A; Tímár L; Karcagi V
Ideggyogy Sz; 2009 Nov; 62(11-12):390-7. PubMed ID: 20025129
[TBL] [Abstract][Full Text] [Related]
43. [Quantitative analysis of SMN gene copies in spinal muscular atrophy].
Ding HX; Yang XS; Xiao B; Wu ZG; Zhang LF
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):153-5. PubMed ID: 15079799
[TBL] [Abstract][Full Text] [Related]
44. Screening of deletions in SMN, NAIP and BTF2p44 genes in Turkish spinal muscular atrophy patients.
Savas S; Gokgoz N; Kayserili H; Ozkinay F; Yuksel-Apak M; Kirdar B
Hum Hered; 2000; 50(3):162-5. PubMed ID: 10686493
[TBL] [Abstract][Full Text] [Related]
45. Neonatal spinal muscular atrophy with multiple contractures, bone fractures, respiratory insufficiency and 5q13 deletion.
García-Cabezas MA; García-Alix A; Martín Y; Gutiérrez M; Hernández C; Rodríguez JI; Morales C
Acta Neuropathol; 2004 May; 107(5):475-8. PubMed ID: 14968368
[TBL] [Abstract][Full Text] [Related]
46. A sensitive assay for measuring SMN mRNA levels in peripheral blood and in muscle samples of patients affected with spinal muscular atrophy.
Vezain M; Saugier-Veber P; Melki J; Toutain A; Bieth E; Husson M; Pedespan JM; Viollet L; Pénisson-Besnier I; Fehrenbach S; Bou J; Frébourg T; Tosi M
Eur J Hum Genet; 2007 Oct; 15(10):1054-62. PubMed ID: 17609673
[TBL] [Abstract][Full Text] [Related]
47. Quantitative analysis of SMN1 and SMN2 genes based on DHPLC: a highly efficient and reliable carrier-screening test.
Su YN; Hung CC; Li H; Lee CN; Cheng WF; Tsao PN; Chang MC; Yu CL; Hsieh WS; Lin WL; Hsu SM
Hum Mutat; 2005 May; 25(5):460-7. PubMed ID: 15832310
[TBL] [Abstract][Full Text] [Related]
48. SMN2 and NAIP gene dosages in Vietnamese patients with spinal muscular atrophy.
Tran VK; Sasongko TH; Hong DD; Hoan NT; Dung VC; Lee MJ; Gunadi ; Takeshima Y; Matsuo M; Nishio H
Pediatr Int; 2008 Jun; 50(3):346-51. PubMed ID: 18533950
[TBL] [Abstract][Full Text] [Related]
49. Genotype-phenotype correlation of SMN locus genes in spinal muscular atrophy patients from India.
Kesari A; Idris MM; Chandak GR; Mittal B
Exp Mol Med; 2005 Jun; 37(3):147-54. PubMed ID: 16000867
[TBL] [Abstract][Full Text] [Related]
50. Spinal Muscular Atrophies: An Ongoing Diagnostic Dilemma?
Biros I; Forshaw K; Sheffield LJ; Kornberg AJ; Forrest S
Mol Diagn; 1997 Dec; 2(4):241-249. PubMed ID: 10462616
[TBL] [Abstract][Full Text] [Related]
51. Best practice guidelines for molecular analysis in spinal muscular atrophy.
Scheffer H; Cobben JM; Matthijs G; Wirth B
Eur J Hum Genet; 2001 Jul; 9(7):484-91. PubMed ID: 11464239
[TBL] [Abstract][Full Text] [Related]
52. Identification of a candidate modifying gene for spinal muscular atrophy by comparative genomics.
Scharf JM; Endrizzi MG; Wetter A; Huang S; Thompson TG; Zerres K; Dietrich WF; Wirth B; Kunkel LM
Nat Genet; 1998 Sep; 20(1):83-6. PubMed ID: 9731538
[TBL] [Abstract][Full Text] [Related]
53. Correlation between severity and SMN protein level in spinal muscular atrophy.
Lefebvre S; Burlet P; Liu Q; Bertrandy S; Clermont O; Munnich A; Dreyfuss G; Melki J
Nat Genet; 1997 Jul; 16(3):265-9. PubMed ID: 9207792
[TBL] [Abstract][Full Text] [Related]
54. Inverse correlation between SMN1 and SMN2 copy numbers: evidence for gene conversion from SMN2 to SMN1.
Ogino S; Gao S; Leonard DG; Paessler M; Wilson RB
Eur J Hum Genet; 2003 Mar; 11(3):275-7. PubMed ID: 12673282
[TBL] [Abstract][Full Text] [Related]
55. Deletion of the SMN1 and NAIP genes in Vietnamese patients with spinal muscular atrophy.
Nguyen DB; Sadewa AH; Takeshima Y; Sutomo R; Tran VK; Nguyen TN; Nguyen TH; Vu CD; Dang DH; Harada Y; Nishio H; Matsuo M
Kobe J Med Sci; 2003; 49(3-4):55-8. PubMed ID: 14676483
[TBL] [Abstract][Full Text] [Related]
56. [Study of NAIP gene in spinal muscular atrophy].
Ma H; Wang Y; Mi Z; Wu Y; Zhao P; Zhao S; Jiang M; Li Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Apr; 16(2):97-8. PubMed ID: 10194256
[TBL] [Abstract][Full Text] [Related]
57. [Phenotype-genotype correspondence in spinal muscular atrophy in a Moroccan family].
They-They TP; Nadifi S; Dehbi H; Bellayou H; Brik H; Slassi I; Itri M
Arch Pediatr; 2008 Jul; 15(7):1201-5. PubMed ID: 18538551
[TBL] [Abstract][Full Text] [Related]
58. Population screening and cascade testing for carriers of SMA.
Smith M; Calabro V; Chong B; Gardiner N; Cowie S; du Sart D
Eur J Hum Genet; 2007 Jul; 15(7):759-66. PubMed ID: 17392705
[TBL] [Abstract][Full Text] [Related]
59. Implementation of SMA carrier testing in genetic laboratories: comparison of two methods for quantifying the SMN1 gene.
Cuscó I; Barceló MJ; Baiget M; Tizzano EF
Hum Mutat; 2002 Dec; 20(6):452-9. PubMed ID: 12442269
[TBL] [Abstract][Full Text] [Related]
60. Molecular analysis of the SMN and NAIP genes in Iranian spinal muscular atrophy patients.
Omrani O; Bonyadi M; Barzgar M
Pediatr Int; 2009 Apr; 51(2):193-6. PubMed ID: 19405914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
